Kihn-Alarcón Alba J, Toledo-Ponce María F, Velarde Angel, Xu Ximing
Instituto Nacional de Cancerología, Guatemala City, Guatemala.
Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
J Glob Oncol. 2019 Feb;5:1-8. doi: 10.1200/JGO.18.00179.
Guatemala has the highest mortality and incidence of liver cancer in Central and South America. The aim of this study is to describe the extent of liver cancer in the country from 2012 to 2016 and the associated risk factors.
A secondary analysis was performed using liver cancer mortality and morbidity data and data on risk factors, such as hepatitis B virus infection, cirrhosis, and alcoholism.
Analysis revealed that liver cancer causes approximately 20% of cancer deaths in the country, is more frequent in the population older than age 65 years old, and is increasing in those age 30 to 44 years. More than 25% of deaths occurred in the North and West regions. The incidence of major risk factors for development of liver cancer has decreased.
The high mortality of liver cancer compared with its incidence indicates that most patients are diagnosed at late stages. To reduce the burden of liver cancer, creation of strategies for earlier detection is needed.
危地马拉在中美洲和南美洲肝癌死亡率和发病率最高。本研究的目的是描述2012年至2016年该国肝癌的发病情况及其相关危险因素。
利用肝癌死亡率和发病率数据以及诸如乙型肝炎病毒感染、肝硬化和酗酒等危险因素的数据进行二次分析。
分析显示,肝癌导致该国约20%的癌症死亡,在65岁以上人群中更为常见,且在30至44岁人群中呈上升趋势。超过25%的死亡发生在北部和西部地区。肝癌主要危险因素的发病率有所下降。
与发病率相比,肝癌的高死亡率表明大多数患者在晚期才被诊断出来。为减轻肝癌负担,需要制定早期检测策略。